Market accessOfficial
AIFA issues sunset clause pre-notice for products at risk of lapsing in early 2027
🇮🇹 AIFA · Tue 17 Nov 2026
Italy's medicines agency has published a warning listing products that could lose authorisation for non-marketing, with lapse dates falling between 1 January and 31 March 2027.
The Italian Medicines Agency (AIFA) published on 17 November 2026 a pre-notice of lapse under the sunset clause. The attached communication lists medicinal products that are potentially at risk of losing their authorisation because they have not been marketed.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (AIFA). AI-assisted; check the source before acting.
More Market access
All →
EEA Joint Committee adds six EU feed additive acts to Annex I of EEA Agreement
🇪🇺 EUR-Lex · Thu 19 Nov 2026
Health Canada flags Beckman Coulter DxC 500i software fault that may distort chemistry results
🇨🇦 Health Canada · Wed 18 Nov 2026
CMS moves Alimetry's Gastric Alimetry test to higher Medicare outpatient payment tier for 2027
Alimetry Inc. · Wed 18 Nov 2026
ANSM amends French generic groups directory in decision dated 12 November 2026
🇫🇷 ANSM · Wed 18 Nov 2026
Slovenia asks wholesalers to import estradiol 50 microgram patches amid supply disruption
🇸🇮 JAZMP · Wed 18 Nov 2026
SÚKL explains why Czech pharmacies may split repeat-prescription dispensing across days
🇨🇿 SÚKL · Wed 18 Nov 2026